The Scotts Miracle-Gro Company

Net leverage is expected to fall below 4.0x with LTM EBITDA of $526.4M and a 10% free cash flow yield. Stifel raised its price target to $79, arguing that each deleveraging step increases the probability of share buybacks, which mechanically reduces float and amplifies EPS — optionality that remains underpriced by the market.

Despite balance-sheet progress, several analysts maintain that debt levels remain a meaningful constraint. Seeking Alpha coverage highlights that mixed execution and limited future debt reduction cap the stock's upside, and multiple analysts retain a 'Hold' rating until further tangible deleveraging is demonstrated.

Near-term seasonal demand and improving retail traffic — up 3.2% per Placer.ai data — support a constructive short-term outlook. Three analysts raised estimates following Q1 FY2026 results that modestly beat on both EPS and revenue, suggesting current cost pressures are manageable in the near term.

JPMorgan downgraded Scotts Miracle-Gro from Overweight to Neutral and cut its price target to $67, citing expected raw-material cost pressure stemming from the Iran conflict. Analysts warn that geopolitically driven input inflation represents a significant earnings risk playing out on a 6–18 month horizon that most models underestimate.

The reclassification of Hawthorne as a discontinued operation signals management's decisive pivot away from the underperforming cannabis-adjacent business. This strategic clarity allows investors to re-focus on the core lawn and garden segment, which recently delivered $4.53 EPS versus the $3.97 consensus estimate and $1.46B in revenue above expectations.

Scotts Miracle-Gro's stock sank on a revenue miss tied to weak hydroponics sales, and Seeking Alpha analysis describes subdued spending and channel inventory build-up as headwinds that reduce upside potential. The prolonged weakness in the cannabis-adjacent hydroponics market has repeatedly undermined overall company performance and analyst confidence.